News

Published on 10 May 2022 on Zacks via Yahoo Finance

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Article preview image

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.

What Are Smart Beta ETFs?

The ETF industry has long been dominated by products based on market cap weighted indexes, a strategy created to reflect the market or a particular market segment.

Read the rest of the article
NYSE.XLV price evolution
NASDAQ.REGN price evolution
NASDAQ.GILD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies...

Following an investigation announced in November last year, the FDA said on Thursday that it woul...

Benzinga 19 Apr 2024
US FDA mandates label updates on CAR-T cancer therapies

The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology...

Reuters 18 Apr 2024
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it mig...

Zacks via Yahoo Finance 16 Apr 2024
Biotech Innovations Paving the Way in Breast Cancer Fight

Broadening our ability to tackle breast cancer are several biotech developments including from...

KAMR Amarillo 11 Apr 2024
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter - Gilead Sciences...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalue...

Benzinga 11 Apr 2024
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Abecma

Bristol Myers Squibb BMY announced that the FDA approved a label expansion for chimeric antigen r...

Zacks via Yahoo Finance 8 Apr 2024
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights

Investing.com 8 Apr 2024
Gilead Sciences acquires $368,790 in Xilio Therapeutics stock

In a recent move, Gilead Sciences, Inc. (NASDAQ: GILD ) has increased its stake in Xilio...

Investing.com 3 Apr 2024
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefo...

Zacks via Yahoo Finance 3 Apr 2024
New HIV case rate in metro Atlanta third highest in nation

The 20-county Atlanta metro area had the third-highest rate of new HIV diagnoses among U.S. metro...

Atlanta Journal-Constitution 1 Apr 2024

Copyright Statfolio @ 2024

Social Accounts